The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

48 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthetic 1,2,3-triazole-linked glycoconjugates bind with high affinity to human galectin-3.EBI
Fcfrp - Usp
Synthesis and evaluation of iminocoumaryl and coumaryl derivatized glycosides as galectin antagonists.EBI
Lund University
Elements and modulation of functional dynamics.EBI
Janssen Research and Development
Tuning the preference of thiodigalactoside- and lactosamine-based ligands to galectin-3 over galectin-1.EBI
Utrecht University
1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors.EBI
The Hashemite University
Galectin-inhibitory thiodigalactoside ester derivatives have antimigratory effects in cultured lung and prostate cancer cells.EBI
Lund University
Synthesis of stable and selective inhibitors of human galectins-1 and -3.EBI
University of Montreal
3-(1,2,3-Triazol-1-yl)-1-thio-galactosides as small, efficient, and hydrolytically stable inhibitors of galectin-3.EBI
Lund University
Synthesis and galectin-binding activities of mercaptododecyl glycosides containing a terminalß-galactosyl group.EBI
National Institute of Advanced Industrial Science and Technology (Aist)
Protein subtype-targeting through ligand epimerization: talose-selectivity of galectin-4 and galectin-8.EBI
Lund University
Discovery of EBI
Peking Union Medical College
Ligand Sulfur Oxidation State Progressively Alters Galectin-3-Ligand Complex Conformations To Induce Affinity-Influencing Hydrogen Bonds.EBI
Lund University
Strong Binding of EBI
University of Debrecen
Synthesis, binding affinity, and inhibitory capacity of cyclodextrin-based multivalent glycan ligands for human galectin-3.EBI
University of Maryland
Discovery of Selective and Orally Available Galectin-1 Inhibitors.EBI
Galecto Biotech
Identification of benzothiazole derived monosaccharides as potent, selective, and orally bioavailable inhibitors of human and mouse galectin-3; a rare example of using a S···O binding interaction for drug design.EBI
Bristol Myers Squibb
Novel Selective Galectin-3 Antagonists Are Cytotoxic to Acute Lymphoblastic Leukemia.EBI
Griffith University
Identification of Monosaccharide Derivatives as Potent, Selective, and Orally Bioavailable Inhibitors of Human and Mouse Galectin-3.EBI
Bristol Myers Squibb
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.EBI
Galecto Biotech
Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel Tetrahydropyran-Based Thiodisaccharide Mimics as Galectin-3 Inhibitors.EBI
Bristol Myers Squibb
Benzimidazole-galactosides bind selectively to the Galectin-8 N-Terminal domain: Structure-based design and optimisation.EBI
Lund University
Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain.EBI
Lund University
Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling.EBI
Stanford University School of Medicine
Novel Galectin-3 Inhibitors for Treating Fibrosis.EBI
Smith, Gambrell & Russell
A Selective Galactose-Coumarin-Derived Galectin-3 Inhibitor Demonstrates Involvement of Galectin-3-glycan Interactions in a Pulmonary Fibrosis Model.EBI
Institute of Science Education and Research-Kolkata (Iiser) Kolkata
Epimers Switch Galectin-9 Domain Selectivity: 3EBI
Lund University
Binding of triazole-linked galactosyl arylsulfonamides to galectin-3 affects Trypanosoma cruzi cell invasion.EBI
University of Sao Paulo
Bivalent O-glycoside mimetics with S/disulfide/Se substitutions and aromatic core: Synthesis, molecular modeling and inhibitory activity on biomedically relevant lectins in assays of increasing physiological relevance.EBI
Ludwig-Maximilians-University Munich
Systematic Tuning of Fluoro-galectin-3 Interactions Provides Thiodigalactoside Derivatives with Single-Digit nM Affinity and High Selectivity.EBI
Lund University
NOVEL COMPOUNDS USEFUL AS STING AGONISTS AND USES THEREOFBDB
Jacobio Pharmaceuticals
INHIBITORS OF METTL3BDB
Strom Therapeutics
Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicamentBDB
China Pharmaceutical University
MODULATORS OF ALPHA-1 ANTITRYPSINBDB
Vertex Pharmaceuticals
INDAZOLE DERIVATIVES AS INHIBITORS OF SARM1BDB
Disarm Therapeutics
Tricyclic amine compounds as CDK2 inhibitorsBDB
Incyte
Pharmaceutical composition for preventing or treating acute myeloid leukemia or metastatic breast cancerBDB
Pelemed
1,8-naphthyridinone compounds and uses thereofBDB
Nuvation Bio
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitorsBDB
Ideaya Biosciences
2-aryl-4-hydroxy-1,3-thiazole derivatives useful as TRPM8-inhibitors in treatment of neuralgia, pain, COPD and asthmaBDB
DompÉ
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the sameBDB
Aclaris Therapeutics
Bicyclic compounds as ATX inhibitorsBDB
Hoffmann-La Roche
Tetrahydrothiophene-based GABA aminotransferase inactivators and analogs thereof for treating neurological disordersBDB
Northwestern University
CXCR4 inhibitors and uses thereofBDB
X4 Pharmaceuticals
Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereofBDB
Pharmaxis
Pyrazolo[1,5-A]PYRAZIN-4-YL derivativesBDB
Pfizer
Inhibitors of PDE10BDB
Bristol-Myers Squibb
Anthrax lethal factor protease inhibitors: synthesis, SAR, and structure-based 3D QSAR studies.BDB
Burnham Institute